Comprehensive analyses of PBRM1 in multiple cancer types and its association with clinical response to immunotherapy and immune infiltrates

BACKGROUND: The prognostic value of polybromo 1 (PBRM1) gene mutations in clear cell renal carcinoma (CCRCC) with anti-programmed death-ligand 1 (PD-L1) therapy remains controversial, and few studies have reported the impact of PBRM1 mutations in other cancer types. METHODS: The patient information...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qiuan, Shen, Rong, Xu, Hanlin, Shi, Xiaoliang, Xu, Lili, Zhang, Lin, Fan, Xinglong, Jin, Xiangfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039713/
https://www.ncbi.nlm.nih.gov/pubmed/33850862
http://dx.doi.org/10.21037/atm-21-289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039713/
https://www.ncbi.nlm.nih.gov/pubmed/33850862
http://dx.doi.org/10.21037/atm-21-289

Ejemplares similares